HAIHE BIOPHARMA
HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company focuses on discovery, development and commercialization of innovative anti-tumor drugs, pharmacological efficacy evaluation and provide products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, enabling customers to improve their health conditions and research quality in an efficient manner.
HAIHE BIOPHARMA
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2011-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.haihepharma.com
Total Employee:
251+
Status:
Active
Contact:
86-(021)-20568888
Email Addresses:
[email protected]
Total Funding:
317.61 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Apache Mobile Non Scaleable Content Euro Microsoft Azure DNS ASP.NET
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Intech Biopharm
Intech Biopharm is a pharmaceutical company that develops, produces and markets specialized drugs focused on respiratory treatment.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Current Employees Featured
Founder
Investors List
CICC
CICC investment in Series B - Haihe Biopharma
Warburg Pincus
Warburg Pincus investment in Series B - Haihe Biopharma
Legend Capital
Legend Capital investment in Series B - Haihe Biopharma
Beijing Langzi Asiana Asset Management
Beijing Langzi Asiana Asset Management investment in Series B - Haihe Biopharma
Winfast Holding
Winfast Holding investment in Series B - Haihe Biopharma
CMB International Capital Corporation
CMB International Capital Corporation investment in Series B - Haihe Biopharma
Chaos Investment
Chaos Investment investment in Series B - Haihe Biopharma
CASVC
CASVC investment in Series B - Haihe Biopharma
Huagai Capital
Huagai Capital investment in Series B - Haihe Biopharma
Daehwa Pharmaceutical
Daehwa Pharmaceutical investment in Series B - Haihe Biopharma
Official Site Inspections
http://www.haihepharma.com
- Host name: 101.32.242.105
- IP address: 101.32.242.105
- Location: Singapore
- Latitude: 1.3667
- Longitude: 103.8
- Timezone: Asia/Singapore
More informations about "Haihe Biopharma"
上海海和药物研究开发股份有限公司|海和药物|海和官网
Academician1 Scientists141 Doctorate Degree29 Number of Employees233 Master’s Degree61 As of FEB.29,2024See details»
上海海和药物研究开发股份有限公司|海和药物|海和官网
海和药物是中国领先的自主创新生物技术公司，专注于抗肿瘤创新药物的发现、开发、生产及商业化，为全球癌症患者带来 ...See details»
海和製薬株式会社
海和製薬株式会社 Inclusive and open to diversity, innovation oriented to win together and benefit the mankind. Haihe Biopharma は革新的な抗腫瘍薬の発見、開発、生産、及び商業化を目指すグローバルバイオテクノロジー企業です。See details»
Shanghai Haihe Pharmaceutical Research & Development Co., Ltd.
Www.haihepharma.com. Last update 08 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. ... The statistics for drugs in the …See details»
Haihe Biopharma - Crunchbase Company Profile & Funding
HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company focuses on discovery, …See details»
Haihe Biopharma - Overview, News & Similar companies - ZoomInfo
Haihe Biopharma contact info: Phone number: +86 2120568888 Website: www.haihepharma.com What does Haihe Biopharma do? Haihe Biopharma is an innovation-driven biotechnology …See details»
Haihe Biopharma Overview | SignalHire Company Profile
Haihe Biopharma is a private company that has been in the industry for 13 years. The company currently specializes in the Hospital & Health Care, Biotechnology, Pharmaceuticals areas. …See details»
Shanghai Haihe Pharmaceutical Research & Development Co., Ltd.
了解Shanghai Haihe Pharmaceutical Research & Development Co., Ltd. (上海海和药物研究开发股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的45项临床试验, 210篇新闻 …See details»
HaiHe Biopharma | Digital Health Corporate Profiles - HealthTech …
Corporates > HaiHe Biopharma. HaiHe Biopharma HaiHe Biopharma Co., Ltd is a biopharmaceutical company focusing on discovery, development and commercialization of …See details»
Haihe Biopharma - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Haihe Biopharma. Use the PitchBook Platform to explore the full profile.See details»
Haihe Biopharma Company Profile - Office Locations, Competitors …
Haihe Biopharma has 5 employees at their 1 location and $317.6 m in total funding,. See insights on Haihe Biopharma including office locations, competitors, revenue, financials, executives, …See details»
Haihe Biopharma - VentureRadar
"HaiHe Biopharma focuses on discovery, development and commercialization of innovative anti-tumor drugs. Guided by our mission, “Inclusive and open to diversity, innovation oriented to …See details»
HaiHe Biopharma - Company Profile - Tracxn
Nov 15, 2024 HaiHe Biopharma ranks 493rd among 2364 active competitors. 850 of its competitors are funded while 549 have exited. Overall, HaiHe Biopharma and its competitors …See details»
HaiHe Biopharma - Products, Competitors, Financials, Employees ...
About HaiHe Biopharma. HaiHe Biopharma focuses on the discovery, development, and commercialization of anti-tumor drugs. It also offers a fully integrated pre-clinical evaluation …See details»
海和製薬株式会社-ニュースリリース - haihepharma.com
2023 年 9 月 8 日. Haihe Biopharma 社 日本法人 海和製薬株式会社. 新規抗がん剤 Gumarontinib （ SCC244 ）に係る. 国内製造販売承認申請のお知らせ . 海和（ハイヘ）製薬株式会社（中国 …See details»
海和生物与石药集团组建合资公司｜联合开发新药项目 | 药时 …
Feb 18, 2019 www.haihepharma.com. 关于石药集团. 石药控股集团有限公司是我国医药行业的龙头企业之一，为在港上市公司（01093.HK），是香港恒生指数成份股，是恒生指数编制50年 …See details»
海和生物分别与上海药物所、泰格医药、君实生物、思路迪医药、 …
Sep 10, 2018 海和生物分别与上海药物所、泰格医药、君实生物、思路迪医药、九洲药业达成战略合作协议See details»
Haihe Pharmaceutical Closed ￥1.20 Billion Series B Financing, …
Shanghai, 27 July 2020— Shanghai Haihe Pharmaceutical Co., Ltd (hereinafter referred to as "Haihe Pharmaceutical"), a leading biotech company focuses on the discovery and …See details»
Julie Pan at Haihe Biopharma - DataLead
Feb 25, 2024 SVP, Head of Business Development and US Operations (Vice President) at Haihe Biopharma. See Julie Pan's email address, phone number and work experience.See details»